Fiche du document
16 septembre 2020
- doi: 10.53738/REVMED.2020.16.706.1690
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.706.1690
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32936550
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5A2DC6BD14CF3
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Service of process Service of papers Abuse of process Process Skilled nursing facilities Long-term skilled nursing facilities Skilled care facilities Nursing facilities, Skilled Blood pressure, High Vascular hypertension High blood pressureCiter ce document
N. Tebib et al., « Déprescription dans le contexte de l’hypertension [Deprescribing antihypertensive therapy] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.706.1690
Métriques
Partage / Export
Résumé
With the rise of life-expectancy, the number of comorbidities can increase and lead to polypharmacy (≥ 5 drugs/day) and excessive polypharmacy (> 9 drugs/day). In order to define suitable therapeutic targets, it is essential to take into account the heterogeneity of this population which can be classified into 3 categories : robust, vulnerable or dependent. In this context, the concept of deprescription, which englobes the process of tapering or stopping drugs, aimed at improving patient outcomes, becomes an important therapeutic tool. In the context of hypertension, this approach seems to be a safe, provided that patients can benefit from regular monitoring. It must be considered in vulnerable and dependent patients or patients institutionalized in nursing homes. Although, scientific evidence slowly accumulates, its levels remain moderate. Finally, the deprescribing process, can also be applied in specifics situations in order to prevent adverse events, such as during a heat wave.